MARIA NAYLOR: Open Payments
NPI 1699406231 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $265 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $309 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $47 |
| PFIZER INC. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $23 |
| LEO Pharma Inc. | 1 | $20 |
| Incyte Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: ERLEADA, RYBREVANT, CIBINQO, ILUMYA, TREMFYA, Rhapsido, DUPIXENT, Bimzelx.
Industry payments across NY — which companies pay providers there.
